Three types of Staphylococcus aureus strains were isolated with respect to streptomycin (SM) and spectinomycin (SPC) resistance, namely, SMrSPCr, SMrSPCS, and SMaSPCr (r, resistant; s, sensitive). Curing experiments and transduction analysis of strain MS7990 (SMr.SPCr.EMr) (EM, erythromycin) disclosed that the loci governing SM and SPC resistance are different and exist on different nontransferable plasmids (r factor), one plasmid carrying the genes governing SM resistance and another possessing the genes governing resistance to both SPC and EM. Strain MS7990 (SMr.SPCr) inactivated both drugs by adenylylation. Similarly, the SMrSPCs and SMSSPCr strains inactivated SM and SPC, respectively, by adenylylation, although the adenylylated positions of both drugs have not been established as yet. The adenylylated SM in staphylococci was shown to be different from 3"-adenylyl-SM, indicating the possibility of the existence of a different enzyme from SM3"-adenylyl transferase demonstrated in Escherichia coli strains.
Three types of Staphylococcus aureus strains were isolated with respect to streptomycin (SM) and spectinomycin (SPC) resistance, namely, SMrSPCr, SMrSPCS, and SMaSPCr (r, resistant; s, sensitive). Curing experiments and transduction analysis of strain MS7990 (SMr.SPCr.EMr) (EM, erythromycin) disclosed that the loci governing SM and SPC resistance are different and exist on different nontransferable plasmids (r factor), one plasmid carrying the genes governing SM resistance and another possessing the genes governing resistance to both SPC and EM. Strain MS7990 (SMr.SPCr) inactivated both drugs by adenylylation. Similarly, the SMrSPCs and SMSSPCr strains inactivated SM and SPC, respectively, by adenylylation, although the adenylylated positions of both drugs have not been established as yet. The adenylylated SM in staphylococci was shown to be different from 3"-adenylyl-SM, indicating the possibility of the existence of a different enzyme from SM3"-adenylyl transferase demonstrated in Escherichia coli strains.
It was reported that streptomycin (SM) was inactivated by cell-free extracts from SM-resistant strains of Escherichia coli (1, 3, 9, 13, 14, 16) and Pseudomonas aeruginosa (2, 5, 7) in the presence of adenosine 5'-triphosphate (ATP) by either adenylylation or phosphorylation of the drug. A SM-resistant but spectinomycin (SPC)-sensitive strain of E. coli carrying an R factor could inactivate SM by phosphorylation (9) . However, the cell-free extract from an SM-and SPC-resistant E. coli strain carrying a different R factor inactivated both SM and SPC by adenylylation, indicating the presence of an enzyme capable of adenylylating both SM and SPC (1, 11) . It is known that in staphylococcal strains SM resistance can be classified into two groups, i.e., intermediate (50 to 400 ,g/ml) and high (1,600 gg/ml or more) resistance. Staphylococcus aureus carrying intermediate SM resistance could inactivate the drug by adenylylation (6) . By contrast, S. aureus possessing high SM resistance could not inactivate the drug under the same conditions; this inactivation mechanism is presently unknown (6) . Re by single-colony isolation. Elimination of resistance was also carried out by cultivating a tested strain at elevated temperature. Overnight broth cultures of tested strains were diluted 1,000-fold with fresh broth and incubated at 42 C. After 7 h of incubation, an appropriate dilution of the culture was spread on an agar plate, and the loss of resistance was examined as described above.
Preparation of cell-free extracts. Cell-free extracts were prepared as described previously (6) .
Inactivation reaction of antibiotics. The SPC inactivation was carried out as described previously (6) , with the antibacterial activity remaining in the reaction mixture determined by bioassay. The concentration of SPC used was 50 gg/ml. The incorporation of isotope from labeled ATP into the drug was investigated by the method of Ozanne et al. ( Electrophoresis of inactivated products. The reaction mixture was pipetted onto a disk of phosphocellulose paper and washed with 100 ml of distilled water. The inactivated product of SM absorbed on the disk was extracted with 15 ml of 0.5 N HCl and lyophilized. The Preparation of phage lysates. Overnight cultures of the donor strains were diluted 100-fold with fresh nutrient broth and shaken at 37 C. After incubation for 4 h, mitomycin C was added (final concentration, 1 gg/ml), and further incubation with shaking was carried out. After incubation for 50 min, 10 ml of the cell culture was centrifuged, and the sedimented cells were suspended in 20 ml of fresh nutrient broth. After 2 h of incubation at 37 C with shaking, the phage lysate was filtered through a membrane disk (type HA; Millipore Corp., Bedford, Mass.). The titer of the lysate thus obtained was about 10' plaque-forming units per ml. In some experiments, a phage lysate from strain MS3878 was propagated on strain MS7990 by the soft-agar technique of Swanstrom and Adams (12) .
Transduction. Recipient cultures and phage lysates were mixed at a multiplicity of infection of 0.2 and incubated at 30 C. After incubation for 40 min, the mixture was washed three times to remove free phage particles. The cell pellet was suspended in nuttrient broth and spread onto HI agar plates containing either SM (25 Ag/ml), SPC (200 ;g/ml), or EM (0.8 jsg/ml). The colonies which developed on selective plates after incubation for 48 h were picked. After three successive single-colony isolations, their drug resistance and phage type were determined. As controls, sterility tests of the phage lysates and mutation of the recipient organisms without phage lysate were carried out. Overnight broth culture without any treatment was plated. (Table 5) . Furthermore, the SM and (SPC.EM)
resistance were found to be cured from the transductants MS3937 (recd) (SMr) and MS3937 (rec-) (SPCr.EMr) by treatment with ethidium bromide, indicating the extrachromosomal existence of the resistance determinants. The resultant SM-sensitive and (SPC.EM)-sensitive strains of MS3937 were found to be still rec-by ultraviolet light sensitivity and by transduction of the penicillin-resistance determinant of PS80 which exists on a chromosome. Biochemical mechanisms of SM and SPC resistance. We have investigated the biochemical mechanisms of SM and SPC resistance by using cell-free extracts from the resistant strains of S. aureus. Strain MS7990 (SMr.SPCr) inactivated both SM and SPC by adenylylation of the drugs (Table 6 ). Singly SM-resistant To confirm the inactivation of SM by adenylylation, electrophoretic analysis of the inactivated products was carried out with an authentic sample of 3"-adenylyl-SM as control. SM and 3"-adenylyl-SM migrate toward the cathode; however, the radioactivity of the inactivated product of SM did not coincide with the authentic sample of 3"-adenylyl-SM, and its mobility was lower than that of 3"-adenylyl-SM (Fig. 1) . DISCUSSION It was reported that the 3-hydroxy group of the N-methyl-L-glucosamine moiety of streptomycin was adenylylated by E. coli strains carrying an R factor (13, 16) . It was also found that a SM-and SPC-resistant strain of E. coli Curing experiments and transduction analysis of MS7990 (SMr.SPCr) indicate that the loci governing SM and SPC resistance exist separately and on different plasmids (for a review, see reference 8), one plasmid carrying the gene governing SM resistance and another one possessing the genes governing both SPC and EM resistance. Biochemical analysis strongly suggests that SM and SPC are inactivated by adenylylation of the drugs, although the adenylylated positions of both drugs are not known at present. Electrophoresis of the inactivated product has shown that the adenylylation of SM by strain MS27 ran toward the cathode but did not coincide with an authentic sample of 3-adenylyl-SM, indicating the existence of an enzyme in staphylococci that adenylylates SM but that is different from the enzyme demonstrated in E. coli strains.
Walker and Skorvaga (15) reported that three enzymes, i.e., streptomycin 6-kinase, dihydrostreptomycin 3'-a-kinase, and streptomycin 3"-kinase, were demonstrated in Streptomyces. This fact also suggests the possibility that the enzymes capable of diadenylylating SM exist in staphylococci.
